The Pathogenesis and Treatment of Optic Disc Swelling in Neurosarcoidosis
A Unique Therapeutic Response to Infliximab
Jeffrey M. Katz, MD;
Michiko Kimura Bruno, MD;
Jacqueline M. S. Winterkorn, MD, PhD;
Nancy Nealon, MD
Arch Neurol. 2003;60:426-430.
Objective To review the pathogenesis and treatment of optic disc swelling in neurosarcoidosis, including a novel therapeutic response to infliximab.
Design and Setting Case reports from an inpatient neurology service.
Patients A 35-year-old woman presented with headache, chronic visual loss, papilledema, and optic atrophy, characteristic of chronic intracranial hypertension. Magnetic resonance imaging showed bifrontal cerebral edema with en plaque frontal pachymeningeal enhancement. Her visual loss progressed despite conventional therapies. The use of the tumor necrosis factor  antagonist infliximab maintained functional vision in her right eye. A 57-year-old woman presented with bilateral, subacute, painful visual loss and unilateral papillitis consistent with optic neuritis. Her visual loss responded rapidly to intravenous corticosteroids. The funduscopic examination findings in both patients prompted further clinical investigation, culminating in the diagnosis of neurosarcoidosis.
Conclusion Understanding the multiple etiologic mechanisms that produce optic disc swelling in sarcoidosis can help neurologists tailor treatment for patients with neurosarcoidosis who present with this symptom.
From the Department of Neurology and Neuroscience, New York Presbyterian Hospital–Weill Medical Center of Cornell University, New York, NY.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society
Wells et al.
Thorax 2008;63:v1-v58.
FULL TEXT
Adalimumab for Treatment of Cutaneous Sarcoidosis
Heffernan and Smith
Arch Dermatol 2006;142:17-19.
FULL TEXT
|
